China poaches Indian scientists to build formulation expertise

China may lead in global API manufacturing, but it wants to move up the food chain and has been enticing Indian scientists with big pay packages to get formulation expertise. The Economic Times reports that Chinese drugmakers are offering up to three times the going rate to get Indian scientists who have both formulation and English language skills. It says that it has picked off 50 to 60 top-level folks, most of whom were already in the country working for Indian companies. Story

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.